Our investors are organizations, businesspeople and individuals who are committed to early-stage entrepreneurial ventures and new technologies in the life sciences and medical devices. They are dedicated to fostering collaborative efforts and a multicultural exchange to accelerate growth and high ROI.
NGT3’s rich deal flow comes from our near-exclusive access to the untapped entrepreneurial potential of the Arab society in Israel, our access within the Jewish sector, and our looking out for the best people, exceptional ideas, and novel technologies.
